New study evaluates the risk for patients with HR+ breast cancer to temporarily hold endocrine therapy in order to get pregnant
A new study examines the use of a seven-gene predictive DCIS biosignature to assess when endocrine therapy may benefit patients following breast-conserving surgery.
The combination of adjuvant chemotherapy and endocrine therapy is no more effective than endocrine therapy alone in improving survival outcomes in patients with early-stage invasive lobular breast cancer, Cleveland Clinic investigators have found.
What research abstracts presented at this year’s American Society of Clinical Oncology annual meeting will have the biggest potential impact on clinical practice? Cleveland Clinic Cancer Center physicians make their picks.